Chemotherapy can impair speech

 

Gothenburg, Sweden (September 6, 2011) – Patients who have received high doses of chemotherapy may find it harder to express themselves verbally, according to new research from the Sahlgrenska Academy at the University of Gothenburg, Sweden. Speech difficulties among cancer patients who received chemotherapy treatment were two times higher than among those who did not.

 

The study has been published in the scientific journal Acta Oncologica. Almost one thousand men who had survived testicular cancer were asked to respond to a questionnaire about how they felt eleven years following their diagnosis.

 

"Those who had undergone chemotherapy were more than twice as likely to report language difficulties as follows: that ‚the words came in the wrong order‘, that they ‚did not say the words they planned to‘ and that they had ‚difficulty finishing sentences,’" says Johanna Skoogh, postgraduate student at the Sahlgrenska Academy, University of Gothenburg in Sweden.

 

Cancer survivors who have received chemotherapy often report difficulties with their memory and ability to concentrate, but researchers have so far been uncertain about whether the impairments experienced can be explained by chemotherapy, as most research is carried out on patients with breast cancer, who are also given hormones that may affect cognitive function.

 

Cognitive function is usually measured using neuropsychological tests. However, in recent years the extent to which these tests can measure difficulties experienced in everyday life has been called into question.

 

"Our questionnaire contains questions about difficulties that patients themselves have said they are troubled by in every-day life. As far as we know, this kind of measuring instrument has not been used in this context before. What also makes our study unique is the high response rate, over 80 percent, and the long follow-up period," says Johanna Skoogh.

 

The researchers behind the study do not rule out the fact that other cognitive functions, such as memory and concentration, may also be affected by high doses of chemotherapy. "Instead we believe language might be especially sensitive when to detect cognitive impairment. After all, language is something that we use every day, which might be why we are quick to notice when our speech function has been affected," says Johanna Skoogh.

 

 


University of Gothenburg, Sweden, 06.09.2011 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…